DSM Acquire US-Based Producer of Urethane Resins

Royal DSM N.V., the leading Life Sciences and Materials Sciences company from the Netherlands, today announces the acquisition of the US-based company Soluol, a developer, producer and marketer of high performance urethane resins which are used in a wide range of applications, with annual sales of USD 20 million. Both parties have agreed not to disclose financial details.

The acquisition of Soluol enhances DSM’s specialty-resins presence in North America and adds new technology as well as a state-of-the-art production facility in Rhode Island. The acquired company will be grouped under the DSM NeoResins+ business unit, part of the DSM Resins business group.

Nico Gerardu, member of DSM’s Managing Board and responsible for the Performance Materials cluster, gave the following comment: “DSM Resins is a strategically very important business in DSM’s accelerated transformation into a leading Life Sciences and Materials Sciences company. The acquisition of Soluol and previously announced investments underline DSM’s belief in the strong growth potential of the resins business and reinforces our geographic presence in the largest coating market in the world, the USA. Soluol’s strong market position, outstanding product portfolio and sharp customer focus are all great fits for DSM NeoResins+.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.